Research advances in diagnosis and treatment of hepatocellular carcinoma complicated by arterioportal shunt
Hepatocellular carcinoma (HCC) complicated by arterioportal shunt (APS) is commonly seen in clinical practice, with an incidence rate of 28.8%-63.2%. It is manifested as abdominal pain, diarrhea, and ascites and can also lead to serious complications of portal hypertension including gastrointestinal...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Hepatology
2017-02-01
|
| Series: | Linchuang Gandanbing Zazhi |
| Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=8023 |